Related Experiment Video
Updated: Jun 23, 2026
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Systemic lupus erythematosus and C1q: A quantitative ELISA for determining C1q levels in serum
Skyler P Dillon1, Anil D'Souza, Biji T Kurien
1Oklahoma Medical Research Foundation, Oklahoma City, 73104, USA.
Insights
Researchers developed a precise new ELISA method to measure C1q levels, crucial for systemic lupus erythematosus (SLE) research. This improved assay offers better reproducibility and efficiency for high-throughput C1q quantification in SLE patients.
Area of Science:
- Immunology and Rheumatology
- Biochemical Assay Development
Background:
- Complement component 1q (C1q) deficiency is linked to systemic lupus erythematosus (SLE).
- Existing methods for C1q quantification show significant variability and reproducibility issues.
- Reported C1q concentrations in non-SLE serum range widely (56-276 microg/mL) due to assay limitations.
Purpose of the Study:
- To develop an improved, precise, and reproducible method for quantifying C1q concentrations.
- To establish a cost-efficient and scalable assay for high-throughput serum C1q measurement.
- To determine a reliable average C1q concentration in non-SLE serum.
Main Methods:
- A novel sandwich enzyme-linked immunosorbent assay (ELISA) was designed for C1q quantification.
- The developed ELISA method was compared against traditional methods like radial immunodiffusion (RID).
- The assay was optimized for precision, cost-efficiency, scalability, and reduced sample volume.
Main Results:
- The new sandwich ELISA demonstrates improved precision and reproducibility compared to existing methods.
- The assay requires significantly smaller serum sample volumes.
- The average C1q concentration in non-SLE serum was determined to be 113 +/- 40 microg/mL.
Conclusions:
- The developed sandwich ELISA offers a superior method for serum C1q quantification.
- This assay is suitable for high-throughput screening and research in systemic lupus erythematosus.
- The improved method addresses limitations of previous C1q measurement techniques.
Abstract:
C1q is of interest in systemic lupus erythematosus (SLE) research due to deficiencies in its activity being associated with the disease. Current published protocols for measuring C1q vary greatly in their results and ease of reproducibility. Due to this, average C1q concentrations have been reported between 56 and 276 microg/mL in non-SLE serum. We present an improved method for quantifying C1q concentrations, which employs a sandwich ELISA. This method has improved precision, cost efficiency, up-scaling, reproducibility, and uses significantly lesser volumes of serum sample when compared to RID and other methods for quantifying C1q. We report an average concentration of 113 +/- 40 microg/mL for C1q in non-SLE serum. The assay designed here will be useful in the high-throughput measurement of serum C1q in SLE cases.
